论文部分内容阅读
目的:评价盐酸氨溴索注射液雾化吸入治疗小儿肺炎患者的临床疗效。方法:选取2013年6月—2014年6月收治的肺炎患儿80例,将其分为对照组和观察组,每组40例;对照组患者均给予常规抗感染及对症治疗,观察组患者在对照组治疗的基础上加用盐酸氨溴索注射液雾化吸入治疗,比较两组患者治疗后的总有效率和并发症发生情况。结果:观察组患者治疗后的总有效率为95.00%,高于对照组为77.50%(P<0.05);并发症发生率为5.00%低于对照组为20.00%(P<0.05)。结论:观察组患者在对照组治疗的基础上加用盐酸氨溴索注射液雾化吸入治疗小儿肺炎患者,可有效提高治疗的总有效率。
Objective: To evaluate the clinical efficacy of ambroxol hydrochloride injection in the treatment of children with pneumonia. Methods: Eighty children with pneumonia admitted from June 2013 to June 2014 were selected and divided into control group and observation group, 40 cases in each group. Patients in control group were given routine anti-infective and symptomatic treatment. Patients in observation group In the control group based on the addition of ambroxol hydrochloride injection inhalation therapy, the two groups of patients after treatment compared the total effective rate and complications. Results: The total effective rate of the observation group was 95.00%, higher than that of the control group (77.50%, P <0.05). The incidence of complications was 5.00% lower than that of the control group (20.00%, P <0.05). Conclusion: The observation group patients in the control group based on the addition of ambroxol hydrochloride injection inhalation treatment of children with pneumonia can effectively improve the total effective rate of treatment.